Results 271 to 280 of about 341,374 (309)

Time course for blood pressure lowering of dihydropyridine calcium channel blockers.

Cochrane Database of Systematic Reviews, 2014
BACKGROUND Calcium channel blockers are a heterogeneous class of drugs, including dihydropyridine and non-dihydropyridine subgroups, commonly used in the treatment of hypertension.
Niousha Ghamami, S. Chiang, C. Dormuth, J. Wright   +3 more
semanticscholar   +1 more source

Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour.

Cochrane Database of Systematic Reviews, 2013
BACKGROUND Calcium channel blocker maintenance therapy is one of the types of tocolytic therapy that may be used after an episode of threatened preterm labour (and usually an initial dose of tocolytic therapy) in an attempt to prevent the onset of ...
Naguesh Naik Gaunekar, P. Raman, Emily Bain, C. Crowther   +3 more
semanticscholar   +1 more source

Cutaneous adverse reactions to calcium channel blockers.

Asian Pacific Journal of Allergy and Immunology, 2013
BACKGROUND Previous studies have shown that calcium channel blockers can cause cutaneous adverse reactions; however, the amounts of data collected are limited. Recently, there have been new drugs available for which only a few reports have been published
P. Tuchinda, K. Kulthanan, S. Khankham, K. Jongjarearnprasert, N. Dhana   +4 more
semanticscholar   +1 more source

Calcium channel blockers and Alzheimer's disease

Neural Regeneration Research, 2012
Alzheimer's disease is characterized by two pathological hallmarks: amyloid plaques and neurofibrillary tangles. In addition, calcium homeostasis is disrupted in the course of human aging.
Y. Tan, Yulin Deng, H. Qing
semanticscholar   +1 more source

Calcium channel blockers for neuroleptic-induced tardive dyskinesia.

Cochrane Database of Systematic Reviews, 2011
BACKGROUND Schizophrenia and related disorders affect a sizable proportion of any population. Neuroleptic (antipsychotic) medications are the primary treatment for these disorders.
A. Essali, Hany Deirawan, K. Soares-Weiser, C. Adams   +3 more
semanticscholar   +1 more source

Calcium channel blockers for the management of preterm birth: a review.

American Journal of Perinatology, 2011
Preterm birth continues to be the leading cause of perinatal morbidity and mortality. A wide range of tocolytics have been utilized for the management of preterm labor.
A. Nassar, J. Aoun, I. Usta
semanticscholar   +1 more source

Calcium Channel Blockers

Mayo Clinic Cardiology, 2020
Peter Brady
semanticscholar   +1 more source

Anti-diabetic Properties of Calcium Channel Blockers: Inhibition Effects on Aldose Reductase Enzyme Activity

Applied Biochemistry and Biotechnology, 2019
Cüneyt Türkeş, Yeliz Demir, Ş. Beydemir   +2 more
semanticscholar   +1 more source

Prior Use of Calcium Channel Blockers Is Associated With Decreased Mortality in Critically Ill Patients With Sepsis: A Prospective Observational Study

Critical Care Medicine, 2017
M. Wiewel, L. V. van Vught, B. Scicluna, A. Hoogendijk, J. Frencken, A. Zwinderman, J. Horn, O. Cremer, M. Bonten, M. Schultz, T. van der Poll   +10 more
semanticscholar   +1 more source

Beta-Blockers and Calcium Channel Blockers: First Line Agents

Cardiovascular Drugs and Therapy, 2016
I. Pascual, C. Morís, P. Avanzas
semanticscholar   +1 more source